← Open Payments lookup

EMILY SKEETERS: Open Payments

NPI 1467786848 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$980 in 41 payments from 11 companies in 2025. Trend: 2023 $738 · 2024 $479 · 2025 $980

Food & beverage: $980
CompanyPaymentsAmount
Astellas Pharma US Inc14$323
MILLICENT US INC6$117
MAYNE PHARMA COMMERCIAL LLC6$115
ABBVIE INC.1$113
Sumitomo Pharma America, Inc.3$86
Exeltis, USA Inc.4$76
Biogen, Inc.3$65
Organon LLC1$30
Bayer Healthcare Pharmaceuticals Inc.1$20
Dexcom, Inc.1$20

Products named: Veozah, VRAYLAR, MYFEMBREE, FEMLYV, SLYND, ZURZUVAE, INTRAROSA, NEXPLANON.

Industry payments across IN — which companies pay providers there.